I'm definitely doing what I promised myself I wouldn't do this time around, but I was thinking about the licensing opportunities once the big boys (Roche, Phillips, Abbott, etc.) actually take a serious look at what this Nanologix's new test is capable of. I wonder how much it would be worth to these multi-billion dollar giants to gain sole rights to such a test for the next 20 years.
With their resources, they could easily and quickly configure this test for all possible cases and steal market share from their competitors while potentially making more margin, and best of all, they may be able to do this while bringing down cost for testing.
$10/share would be a steal, but I would take it just to be able to close the book on this long journey. BUT then I would be tempted to acquire shares of the acquiring company. And I think I would have the early bird advantage on this since shareholders of the acquiring company would be like "WT-EFF? Why are we paying $1.6B for a little pink company!?"
OK time to put this genie back into its bottle. Whisper of a dream.....
With their resources, they could easily and quickly configure this test for all possible cases and steal market share from their competitors while potentially making more margin, and best of all, they may be able to do this while bringing down cost for testing.
$10/share would be a steal, but I would take it just to be able to close the book on this long journey. BUT then I would be tempted to acquire shares of the acquiring company. And I think I would have the early bird advantage on this since shareholders of the acquiring company would be like "WT-EFF? Why are we paying $1.6B for a little pink company!?"
OK time to put this genie back into its bottle. Whisper of a dream.....
2
1
